Matthew Wyatt Booth

US Patent:

6800279, Oct 5, 2004

Filed:

May 4, 2001

Appl. No.:

09/848236

Inventors:

Ulrich R. Bernier - Gainesville FL
Donald R. Barnard - Gainesville FL
Matthew M. Booth - Gainesville FL
Daniel L. Kline - Gainesville FL
Kenneth H. Posey - Gainesville FL
Richard A. Yost - Gainesville FL

Assignee:

The United States of America as represented by the Secretary of the Agriculture - Washington DC
University of Florida - Gainesville FL

International Classification:

A01N 2500

US Classification:

424 84, 514557, 514675, 514706, 514724

Abstract:

Compositions and methods employing the compositions for attracting arthropods. The compositions comprise at least one compound of formula I and at least one compound from group II.

US Patent:

7771713, Aug 10, 2010

Filed:

Sep 26, 2003

Appl. No.:

10/670598

Inventors:

Ulrich Bernier - Gainesville FL, US
Donald Barnard - Gainesville FL, US
Matthew Booth - Gainesville FL, US
Daniel Kline - Gainesville FL, US
Kenneth Posey - Gainesville FL, US
Richard Yost - Gainesville FL, US

International Classification:

A01N 31/02
A01N 35/00
A01N 37/00

US Classification:

424 84

Abstract:

Compositions and methods employing the compositions for attracting arthropods. The compositions comprise at least one compound of formula I and at least one compound from group II.

US Patent:

7914460, Mar 29, 2011

Filed:

Aug 15, 2006

Appl. No.:

11/504335

Inventors:

Richard J. Melker - Gainesville FL, US
David G. Bjoraker - Gainesville FL, US
Donn M. Dennis - Gainesville FL, US
Jon D. Stewart - Gainesville FL, US
Christopher D. Batich - Gainesville FL, US
Matthew M. Booth - Gainesville FL, US
Ronald E. Youngblood - Williston FL, US

Assignee:

University of Florida Research Foundation, Inc. - Gainesville FL
Xhale, Inc. - Gainesville FL

International Classification:

A61B 5/08
A61B 5/00

US Classification:

600532, 600365, 600529, 600543

Abstract:

The present invention provides systems and methods for analyzing glucose present in exhaled breath condensate (EBC). In certain embodiments of the invention, electrochemical- or coulometric-based sensing technologies are used to analyze EBC for the presence and/or concentration of glucose.

US Patent:

8053464, Nov 8, 2011

Filed:

Mar 7, 2008

Appl. No.:

12/044213

Inventors:

Brian P. Quinn - Alachua FL, US
David A. Carlson - Gainesville FL, US
Christopher J. Geden - Gainesville FL, US
Ulrich R. Bernier - Gainesville FL, US
Matthew M. Booth - Gainesville FL, US

Assignee:

The United States of America as represented by the Secretary of Agriculture - Washington DC
University of Florida Research Foundation Incorporated - Gainesville FL

International Classification:

A01N 43/36
A01P 19/00

US Classification:

514423

Abstract:

A composition containing at least two members of the group consisting of propionic acid, benzoic acid, 2,6-dimethoxyphenol, 2-acetylpyrrole, 2-hydroxy-3-methyl-2-cyclopentanone, 2-methyltetrahydrofuran-3-one, and 3-methylbutanal; and water, and optionally a carrier or carrier material. The composition is useful for attracting insects (e. g. , flies). A method for attracting insects (e. g. , flies) involving treating an object or area with an insect attracting effective amount of the composition described herein.

US Patent:

20070224128, Sep 27, 2007

Filed:

Mar 7, 2007

Appl. No.:

11/715197

Inventors:

Donn Michael Dennis - Gainesville FL, US
Richard J. Melker - Gainesville FL, US
Matthew M. Booth - Gainesville FL, US
Laszlo Prokai - Mansfield TX, US

International Classification:

A61K 49/00
G01N 33/497

US Classification:

424 101, 73 233

Abstract:

The present invention provides novel methods for monitoring subject adherence in taking prescribed drugs by detecting markers in exhaled breath after a subject takes the prescribed drug. In particular, the present invention provides novel methods for making additives that are combined with the drug(s). Upon biological breakdown of the drug/additive formulation in a subject's body, markers resulting directly from the biological breakdown of the additives are detected in exhaled breath using sensor technology. In certain embodiments of the invention, the drug adherence monitoring systems and methods include a reporting system capable of tracking subject compliance (either remotely or proximately) and of providing necessary alerts to the subject, caregiver, healthcare provider, and the like.

US Patent:

20100216175, Aug 26, 2010

Filed:

Aug 15, 2007

Appl. No.:

12/374564

Inventors:

Richard J. Melker - Gainesville FL, US
David G. Bjoraker - Gainesville FL, US
Donn Michael Dennis - Gainesville FL, US
Jon Dale Stewart - Gainesville FL, US
Christopher D. Batich - Gainesville FL, US
Matthew M. Booth - Gainesville FL, US
John Frederick Horn - Orange Park FL, US
Ronald Youngblood - Williston FL, US
Timothy E. Morey - Gainesville FL, US

International Classification:

C12Q 1/54
C12M 1/34
G01N 33/497
G01N 27/26

US Classification:

435 14, 422 84, 4352879, 436 95, 20440301, 20440314

Abstract:

Systems and methods for analyzing glucose present in exhaled breath condensate (EBC). In certain embodiments, electrochemical- or coulometnc-based sensing technologies are used to analyze EBC for the presence and/or concentration of glucose. Based on the detected glucose m EBC, the subject invention provides systems and methods for non-invasive, accurate assessment of blood glucose levels.

US Patent:

62679538, Jul 31, 2001

Filed:

May 4, 1999

Appl. No.:

9/304362

Inventors:

Ulrich R. Bernier - Gainesville FL
Daniel L. Kline - Gainesville FL
Donald R. Barnard - Gainesville FL
Kenneth H. Posey - Gainesville FL
Matthew M. Booth - Gainesville FL
Richard A. Yost - Gainesville FL

Assignee:

The United States of America as represented by the Secretary of Agriculture - Washington DC

International Classification:

A01N 2500
A01N 3100
A01N 3500
A01N 3700
A01N 4112

US Classification:

424 84

Abstract:

Compositions and methods employing the compositions for attracting arthropods. The compositions comprise at least one compound of formula I and at least one compound from group II.